AmerisourceBergen Develops Tool That Can Expand, Diversify Clinical Trial Populations
AmerisourceBergen, has launched Clinical Trial Navigator, a tool that assists with biopharmaceutical clinical trial recruitment specifically within community-based specialty practices. The solution suite unites oncology practices and their patients with trials through digital site selection, patient identification, and enrollment tools.
Clinical Trial Navigator connects biopharmaceutical companies with over 700 medical practices and 4,700 physicians treating 245,000 patients per month. Drug companies can enter key protocol criteria into the Navigator, adding biomarkers and treatment regimens that patients must have received to quality for a trial.
Jennifer Sherak, senior vice president and president of specialty physician services for AmerisourceBergen said, "Historically, it has been difficult for biopharmaceutical companies to have a consolidated and holistic view of independent specialty practices and their patient populations and, as a result, clinical trial enrollment and logistics in these care settings have been complex and difficult to execute. With Clinical Trial Navigator, we want to break down these barriers for biopharma companies, bring more clinical trials into communities nationwide, help broaden the patient populations being considered for trials, and ultimately advance accrual time and bring therapies to market faster. By creating this connectivity, we also hope to generate more equitable and accessible trial opportunities for underrepresented racial and ethnic groups, rural patients, older adults, and other underserved communities."
.png){kind=small}
.jpg "Discovery Accelerator")
